Three Ways Patients and Advocates Can Inform Rare Disease Trials
PPD
JANUARY 5, 2023
In our survey, patient recruitment and retention remain significant concerns cited by clinical trial sponsors across all therapies. Research by Global Data finds that more than one out of four rare disease clinical trials terminate due to low patient accrual rates. Expand access with decentralized clinical trials (DCTs).
Let's personalize your content